Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in Qatar.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Atopic Dermatitis
  • Diabetes
  • Asthma
  • Nasal Polyps
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Pertussis & Polio
    • Meningitis
  • Multiple Sclerosis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
  • Atopic Dermatitis
  • Rare Diseases
  • Nasal Polyps
PRODUCTS
  • PRODUCTS
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Clexane®
  • Plavix®
  • Apidra®
  • Zympass®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
  • Praluent®
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
  • Lantus®
  • Aubagio®
  • Lemtrada®
  • Amaryl®
  • Depakine®
Home | go to homepage
Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Atopic Dermatitis
  • Diabetes
  • Asthma
  • Nasal Polyps
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Pertussis & Polio
    • Meningitis
  • Multiple Sclerosis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Pre-Ramadan assessment and Risk calculation for diabetic patients during Ramadan
  • Atopic Dermatitis
  • Rare Diseases
  • Nasal Polyps
PRODUCTS
  • PRODUCTS
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Clexane®
  • Plavix®
  • Apidra®
  • Zympass®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
  • Praluent®
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
  • Lantus®
  • Aubagio®
  • Lemtrada®
  • Amaryl®
  • Depakine®
  • LOGIN
  • REGISTER
  • SEARCH
    • Home
    • Science
    • Cardiovascular
    • Atherothrombosis

    Atherothrombosis

    Discover more on science updates, events, KOLs interviews and more on Atherothrombosis

    Science in Atherothrombosis

    Get a 360º view and stay up-to-date on Atherothrombosis with content selected for you

    In hospital outcomes in young patients with AMI: Results from Gulf Coast

    Adherence and persistence analysis in patients treated with DAPT

    Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)

    Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

    Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?

    SEE EVERYTHING

    Inspiration and innovation

    Get inspired and stay at the forefront of innovation with the following resources

    Understanding de-escalation in antiplatelet therapy

    Single antiplatelet therapy Insights on earlier use

    Management of antithrombotic therapy in patients with AF undergoing PCI

    Clopidogrel as the standard of care for elective PCI: Findings from the ALPHEUS

    SEE EVERYTHING
    Home | go to homepage

    SANOFI, Level 3, One JLT, Jumeirah Lake Towers (JLT), DMCC, PO Box 53899, Dubai, UAE |

    Tel.: +971 4 550 3600 | Fax: +971 4 5521050

    For further Medical Information:

    please contact: +971 565776791 or Email: medical-information.gulf@sanofi.com

    To report an adverse event:

    please call: +971 561747001 or Email: Gulf.pharmacovigilance@sanofi.com

    To report any product technical complaints, kindly contact: Email: quality.greatergulf@sanofi.com

     

    MAT-QA-2100056/V2/Nov 2021

    • Legal notice
    • Cookie policy
    • Privacy Policy
    • Sitemap
    • Change country

    YOU WILL NOW BE LEAVING THE SITE

    By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
    Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

    Continue
    This website is intended exclusively for healthcare professionals residing and/or working in the Qatar.
     
    Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.